No Data
Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.
Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).
K Pharma: Financial results announcement for the second quarter (interim period) of December 2024, based on Japanese accounting standards (non-consolidated).
K Pharma: Financial results briefing materials for the second quarter (interim period) of December 2024.
K Pharma: Half Year Report - Term 8 (2024/01/01 - 2024/12/31)
Skylark, Dentsu G, Ebara, Asahi Intec (14th)
*The above calendar is subject to change due to company circumstances. --------------------------------------- August 14th (Wed) <1380> Akikawa Bokuen <1443> GikenHD <147A> Solacom <1491> Chugai Mining <149A> Shinka <157A> Green Monster <160A> Az Partners <1711> SDSHD 1
Volume change rate ranking (10 o'clock) - Almedio, First Copo and other companies are ranked.
*In volume change rate ranking, by comparing the volume of the latest 5 days and the volume on the day of delivery, you can know the market participants' concerns such as the tendency of scouting. ■ Change in trading volume rate Top [June 25, 10:32] (compared to the average trading volume of the latest 5 days) Security Code Security Name Volume 5-day average volume Volume change rate Share price change rate <2625> iFTPX Year 4 173158 83215.773 391.5% 0.013
No Data
No Data